gitaloxin

gitaloxin structure

CAS No.: 3261-53-8

Chemical Name:: gitaloxin

Synonyms: gitaloxin;16-Formylgitoxin;3β-[[4-O-[4-O-(2,6-Dideoxy-β-D-ribo-hexopyranosyl)-2,6-dideoxy-β-D-ribo-hexopyranosyl]-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy]-16β-formyloxy-14-hydroxy-5β,14β-card-20(22)-enolide;Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-16-(formyloxy)-14-hydroxy-, (3β,5β,16β)-;[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate;[3-[5-[5-(4,5-dihydroxy-6-methyl-oxan-2-yl)oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] methanoate;formic acid [3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-hydroxy-17-(5-keto-2H-furan-3-yl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ester

CBNumber:: CB6877110

Molecular Formula:: C42H64O15

Molecular Weight:: 808.95

MDL Number:: MFCD00046279

MOL File:: 3261-53-8.mol

Last updated:2022-12-21 16:56:50

Request For Quotation

gitaloxin Properties

Melting point	251.5°C
Boiling point	674.74°C (rough estimate)
Density	1.1231 (rough estimate)
refractive index	1.5940 (estimate)
FDA UNII	H25D0X8L90

gitaloxin price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
American Custom Chemicals Corporation	TOX0000046	GITALOXIN 95.00%	3261-53-8	5MG	$496.85	2021-12-16	Buy

Product number	Packaging	Price	Buy
TOX0000046	5MG	$496.85	Buy

gitaloxin Chemical Properties,Uses,Production

Originator

Gitaloxin,Shanghai Lansheng Corporation

Definition

ChEBI: A cardenolide glycoside that is gitoxin in which the 16beta-hydroxy group has been formylated.

Manufacturing Process

0.2 g gitoxin was dissolved in 15 ml of dimethylformamide and mixed with 2 ml of acetanhydride, 3 ml formic acid (98%) and 2 ml triethylamine or pyridine. The reaction mixture stood for 60 min. at room temperature, then it was diluted with water, a precipitated product was filtered off. A filtrate was shook with chloroform 2 times. Chloroform was distilled to dryness and the residue was added to the precipitate. 16-Formylgitoxin was isolated by fraction crystallization. MP: 250°-253°C, yield about 50%.

Therapeutic Function

Cardiotonic

gitaloxin Preparation Products And Raw materials

Raw materials

Triethylamine Formic acid Acetic anhydride GITOXIN

Preparation Products

gitaloxin Suppliers

Global( 5)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Leancare Ltd.	--	enquiry@leancare.co.uk	United Kingdom	6460	42
Lanospharma Laboratories Co.,Ltd	--	sales@lanospharma.com	China	6343	56
2A PharmaChem USA	--	sales@2apharmachem.com	United States	6148	39
Shanghai New Union Textra Import & Export Co., Ltd	--	zhou@pharmchemical.com	China	2752	60
3B Scientific Corporation	--	sales@3bsc.com	United States	6744	47

Supplier	Advantage
Leancare Ltd.	42
Lanospharma Laboratories Co.,Ltd	56
2A PharmaChem USA	39
Shanghai New Union Textra Import & Export Co., Ltd	60
3B Scientific Corporation	47

gitaloxin 16-Formylgitoxin 3β-[[4-O-[4-O-(2,6-Dideoxy-β-D-ribo-hexopyranosyl)-2,6-dideoxy-β-D-ribo-hexopyranosyl]-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy]-16β-formyloxy-14-hydroxy-5β,14β-card-20(22)-enolide [3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate [3-[5-[5-(4,5-dihydroxy-6-methyl-oxan-2-yl)oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] methanoate formic acid [3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-hydroxy-17-(5-keto-2H-furan-3-yl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] ester Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-16-(formyloxy)-14-hydroxy-, (3β,5β,16β)- 3261-53-8 C42H64O15